Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
This approach is best suited to: Adults 4065 with longevity-focused health goals who are already engaged in foundational health optimisation (sleep, nutrition, resistance training, metabolic health) Individuals with confirmed age-related decline in GH/IGF-1, with symptoms including reduced lean mass, increased visceral fat, impaired recovery, or sleep-quality deterioration Patients with chronically elevated inflammatory markers without acute disease Adults with disrupted circadian rhythm or age-related sleep degradation (Epitalon specifically addresses this) Those who have optimised foundational lifestyle variables and want an additional, evidence-informed intervention layer It is not appropriate as a standalone intervention for adults who have not addressed metabolic health, sleep, or body composition fundamentals
Tirzepatide's shortage was determined resolved (late 2024) and semaglutide's in February 2025
b) the widespread use of antibiotics in animal farming, which impairs B12 production by the animal gut microbiota
(R)-alpha-lipoic acid oral liquid formulation: pharmacokinetic parameters and therapeutic efficacy
Tirzepatide : You may have heard of this breakthrough medication under brand names like Mounjaro or Zepbound
The pharmaceutical giant previously said it would submit an application as early as this year for the weekly injection, retatrutide, which works differently and appears to be more effective than existing shots and pills
US$ 24.00
US$ 27.01
US$ 22.82
,aspect=ignore)
US$ 29.19
US$ 24.72
